U.S. PHYSICAL THERAPY INC (USPH) Stock Fundamental Analysis
NYSE:USPH - US90337L1089 - Common Stock
81.02 USD
-3.34 (-3.96%)
81.02 USD
0 (0%)
Taking everything into account, USPH scores 5 out of 10 in our fundamental rating. USPH was compared to 101 industry peers in the Health Care Providers & Services industry. Both the profitability and the financial health of USPH get a neutral evaluation. Nothing too spectacular is happening here. USPH is quite expensive at the moment. It does show a decent growth rate.
1. Profitability
1.1 Basic Checks
USPH had positive earnings in the past year.
USPH had a positive operating cash flow in the past year.
USPH had positive earnings in each of the past 5 years.
Each year in the past 5 years USPH had a positive operating cash flow.
1.2 Ratios
With a decent Return On Assets value of 2.93%, USPH is doing good in the industry, outperforming 64.36% of the companies in the same industry.
With a decent Return On Equity value of 6.91%, USPH is doing good in the industry, outperforming 66.34% of the companies in the same industry.
USPH's Return On Invested Capital of 5.72% is fine compared to the rest of the industry. USPH outperforms 60.40% of its industry peers.
The Average Return On Invested Capital over the past 3 years for USPH is below the industry average of 9.19%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.93% | ||
| ROE | 6.91% | ||
| ROIC | 5.72% |
ROA(3y)2.54%
ROA(5y)3.42%
ROE(3y)6.25%
ROE(5y)8.16%
ROIC(3y)5.78%
ROIC(5y)6.77%
1.3 Margins
USPH has a better Profit Margin (4.74%) than 76.24% of its industry peers.
In the last couple of years the Profit Margin of USPH has declined.
USPH has a better Operating Margin (11.00%) than 81.19% of its industry peers.
USPH's Operating Margin has declined in the last couple of years.
With a Gross Margin value of 18.96%, USPH is not doing good in the industry: 60.40% of the companies in the same industry are doing better.
In the last couple of years the Gross Margin of USPH has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 11% | ||
| PM (TTM) | 4.74% | ||
| GM | 18.96% |
OM growth 3Y-9.96%
OM growth 5Y-5.7%
PM growth 3Y-13.05%
PM growth 5Y-8.65%
GM growth 3Y-6.9%
GM growth 5Y-3.92%
2. Health
2.1 Basic Checks
USPH has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, USPH has more shares outstanding
The number of shares outstanding for USPH has been increased compared to 5 years ago.
Compared to 1 year ago, USPH has an improved debt to assets ratio.
2.2 Solvency
USPH has an Altman-Z score of 2.28. This is not the best score and indicates that USPH is in the grey zone with still only limited risk for bankruptcy at the moment.
USPH has a Altman-Z score (2.28) which is in line with its industry peers.
USPH has a debt to FCF ratio of 2.63. This is a good value and a sign of high solvency as USPH would need 2.63 years to pay back of all of its debts.
USPH has a Debt to FCF ratio of 2.63. This is amongst the best in the industry. USPH outperforms 81.19% of its industry peers.
USPH has a Debt/Equity ratio of 0.30. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.30, USPH is in the better half of the industry, outperforming 65.35% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.3 | ||
| Debt/FCF | 2.63 | ||
| Altman-Z | 2.28 |
ROIC/WACC0.68
WACC8.45%
2.3 Liquidity
A Current Ratio of 1.18 indicates that USPH should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.18, USPH is doing worse than 61.39% of the companies in the same industry.
USPH has a Quick Ratio of 1.18. This is a normal value and indicates that USPH is financially healthy and should not expect problems in meeting its short term obligations.
USPH has a Quick ratio of 1.18. This is comparable to the rest of the industry: USPH outperforms 42.57% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.18 | ||
| Quick Ratio | 1.18 |
3. Growth
3.1 Past
USPH shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 7.35%.
The Earnings Per Share has been decreasing by -1.76% on average over the past years.
USPH shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 16.24%.
USPH shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 6.85% yearly.
EPS 1Y (TTM)7.35%
EPS 3Y-6.63%
EPS 5Y-1.76%
EPS Q2Q%10.96%
Revenue 1Y (TTM)16.24%
Revenue growth 3Y10.69%
Revenue growth 5Y6.85%
Sales Q2Q%18.04%
3.2 Future
USPH is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 6.44% yearly.
Based on estimates for the next years, USPH will show a quite strong growth in Revenue. The Revenue will grow by 10.47% on average per year.
EPS Next Y3.98%
EPS Next 2Y9.52%
EPS Next 3Y6.44%
EPS Next 5YN/A
Revenue Next Year16.2%
Revenue Next 2Y11.02%
Revenue Next 3Y10.47%
Revenue Next 5YN/A
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
USPH is valuated quite expensively with a Price/Earnings ratio of 30.81.
USPH's Price/Earnings ratio is in line with the industry average.
USPH is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 27.03, which is the current average of the S&P500 Index.
With a Price/Forward Earnings ratio of 26.18, USPH can be considered very expensive at the moment.
USPH's Price/Forward Earnings is on the same level as the industry average.
USPH is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 22.54, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 30.81 | ||
| Fwd PE | 26.18 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of USPH is on the same level as its industry peers.
USPH's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. USPH is cheaper than 62.38% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 20.23 | ||
| EV/EBITDA | 13.77 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
PEG (NY)7.75
PEG (5Y)N/A
EPS Next 2Y9.52%
EPS Next 3Y6.44%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 2.10%, USPH has a reasonable but not impressive dividend return.
USPH's Dividend Yield is rather good when compared to the industry average which is at 2.48. USPH pays more dividend than 91.09% of the companies in the same industry.
USPH's Dividend Yield is comparable with the S&P500 average which is at 2.45.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.1% |
5.2 History
On average, the dividend of USPH grows each year by 9.09%, which is quite nice.
USPH has been paying a dividend for at least 10 years, so it has a reliable track record.
USPH has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)9.09%
Div Incr Years4
Div Non Decr Years4
5.3 Sustainability
77.94% of the earnings are spent on dividend by USPH. This is not a sustainable payout ratio.
The dividend of USPH is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP77.94%
EPS Next 2Y9.52%
EPS Next 3Y6.44%
81.02
-3.34 (-3.96%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners102.22%
Inst Owner Change1.58%
Ins Owners1.9%
Ins Owner Change0.47%
Market Cap1.23B
Analysts84.62
Price Target108.32 (33.7%)
Short Float %4.39%
Short Ratio3.34
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.1% |
Yearly Dividend1.76
Dividend Growth(5Y)9.09%
DP77.94%
Div Incr Years4
Div Non Decr Years4
Ex-Date
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)10.25%
Min EPS beat(2)9.44%
Max EPS beat(2)11.07%
EPS beat(4)2
Avg EPS beat(4)2.96%
Min EPS beat(4)-7.64%
Max EPS beat(4)11.07%
EPS beat(8)3
Avg EPS beat(8)-1.31%
EPS beat(12)5
Avg EPS beat(12)-0.32%
EPS beat(16)8
Avg EPS beat(16)0%
Revenue beat(2)2
Avg Revenue beat(2)1.85%
Min Revenue beat(2)1.65%
Max Revenue beat(2)2.04%
Revenue beat(4)4
Avg Revenue beat(4)1.28%
Min Revenue beat(4)0.22%
Max Revenue beat(4)2.04%
Revenue beat(8)6
Avg Revenue beat(8)0.67%
Revenue beat(12)7
Avg Revenue beat(12)0.35%
Revenue beat(16)8
Avg Revenue beat(16)-0.06%
PT rev (1m)0.95%
PT rev (3m)0.95%
EPS NQ rev (1m)0.25%
EPS NQ rev (3m)-5.63%
EPS NY rev (1m)3.46%
EPS NY rev (3m)2.6%
Revenue NQ rev (1m)1.67%
Revenue NQ rev (3m)2.11%
Revenue NY rev (1m)1.77%
Revenue NY rev (3m)1.77%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 30.81 | ||
| Fwd PE | 26.18 | ||
| P/S | 1.69 | ||
| P/FCF | 20.23 | ||
| P/OCF | 17.17 | ||
| P/B | 2.46 | ||
| P/tB | N/A | ||
| EV/EBITDA | 13.77 |
EPS(TTM)2.63
EY3.25%
EPS(NY)3.09
Fwd EY3.82%
FCF(TTM)4
FCFY4.94%
OCF(TTM)4.72
OCFY5.82%
SpS48
BVpS32.94
TBVpS-23.19
PEG (NY)7.75
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.93% | ||
| ROE | 6.91% | ||
| ROCE | 7.57% | ||
| ROIC | 5.72% | ||
| ROICexc | 5.91% | ||
| ROICexgc | 34.97% | ||
| OM | 11% | ||
| PM (TTM) | 4.74% | ||
| GM | 18.96% | ||
| FCFM | 8.34% |
ROA(3y)2.54%
ROA(5y)3.42%
ROE(3y)6.25%
ROE(5y)8.16%
ROIC(3y)5.78%
ROIC(5y)6.77%
ROICexc(3y)6.35%
ROICexc(5y)7.3%
ROICexgc(3y)37.05%
ROICexgc(5y)44.29%
ROCE(3y)7.65%
ROCE(5y)8.96%
ROICexcg growth 3Y-11.04%
ROICexcg growth 5Y-7.52%
ROICexc growth 3Y-14.51%
ROICexc growth 5Y-13.29%
OM growth 3Y-9.96%
OM growth 5Y-5.7%
PM growth 3Y-13.05%
PM growth 5Y-8.65%
GM growth 3Y-6.9%
GM growth 5Y-3.92%
F-Score6
Asset Turnover0.62
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.3 | ||
| Debt/FCF | 2.63 | ||
| Debt/EBITDA | 1.49 | ||
| Cap/Depr | 49.29% | ||
| Cap/Sales | 1.49% | ||
| Interest Coverage | 9.81 | ||
| Cash Conversion | 70.13% | ||
| Profit Quality | 176.01% | ||
| Current Ratio | 1.18 | ||
| Quick Ratio | 1.18 | ||
| Altman-Z | 2.28 |
F-Score6
WACC8.45%
ROIC/WACC0.68
Cap/Depr(3y)54.79%
Cap/Depr(5y)61.53%
Cap/Sales(3y)1.47%
Cap/Sales(5y)1.57%
Profit Quality(3y)269.82%
Profit Quality(5y)263.85%
High Growth Momentum
Growth
EPS 1Y (TTM)7.35%
EPS 3Y-6.63%
EPS 5Y-1.76%
EPS Q2Q%10.96%
EPS Next Y3.98%
EPS Next 2Y9.52%
EPS Next 3Y6.44%
EPS Next 5YN/A
Revenue 1Y (TTM)16.24%
Revenue growth 3Y10.69%
Revenue growth 5Y6.85%
Sales Q2Q%18.04%
Revenue Next Year16.2%
Revenue Next 2Y11.02%
Revenue Next 3Y10.47%
Revenue Next 5YN/A
EBIT growth 1Y19.82%
EBIT growth 3Y-0.34%
EBIT growth 5Y0.76%
EBIT Next Year34.6%
EBIT Next 3Y17.41%
EBIT Next 5YN/A
FCF growth 1Y-1.2%
FCF growth 3Y-1.21%
FCF growth 5Y4.7%
OCF growth 1Y2.73%
OCF growth 3Y-0.65%
OCF growth 5Y3.71%